Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr)

Inorganic Chemistry

Volumn 40, Issue 17, 2001, Pages 4310-4318

  Keire, D A ^b,c   Yun Hee Jang, ^a   Li, L ^b   Dasgupta, S ^a   Goddard III, W A ^a   Shively, J E ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7 TRIS(CARBOXYMETHYL) 1,4,7,10 TETRAAZACYCLODODECANE; 1,4,7 TRIS(CARBOXYMETHYL) 10 (CARBOXYETHYL) 1,4,7,10 TETRAAZACYCLODODECANE; 1,4,7,10 TETRA(CARBOXYETHYL) 1,4,7,10 TETRAAZACYCLODODECANE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAKIS(CARBOXYETHYL) 1,4,7,10 TETRAAZACYCLODODECANE; 1,4,7,10-TETRA(CARBOXYETHYL)-1,4,7,10-TETRAAZACYCLODODECANE; 1,4,7-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCLODODECANE; ACETIC ACID DERIVATIVE; AMINE; CHELATING AGENT; HETEROCYCLIC COMPOUNDS, 1 RING; MACROCYCLIC COMPOUND; METAL; PROPIONIC ACID DERIVATIVE; PROTON; RADIOPHARMACEUTICAL AGENT; SINGLE HETEROCYCLIC RINGS; UNCLASSIFIED DRUG; YTTRIUM;

ARTICLE; CALCULATION; CHELATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; DRUG PURIFICATION; DRUG SYNTHESIS; KINETICS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PKA; PROTON TRANSPORT; RADIOIMMUNOTHERAPY;

ACETIC ACIDS; CHELATING AGENTS; HETEROCYCLIC COMPOUNDS, 1-RING; HYDROGEN-ION CONCENTRATION; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROPIONIC ACIDS; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS;

EID: 0035854927     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic0010297     Document Type: Article

References (50)